Gilead Sciences, Inc. (GILD)
$46.39
-0.13 (-0.28%)
| CAPS Rating |
|
|---|---|
| Open | $46.29 |
| Previous Close | $46.52 |
| Daily Range | $46.04 - $46.64 |
| 52-Week Range | $39.37 - $53.28 |
| Market Cap | $41.75B |
| P/E Ratio | 17.49 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 4,936,207 |
| Average Daily Volume | 8,592,000 |
GILD
VS S&P 500 (SPY)
How do you think GILD will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
GILD Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
GILD News and Commentary
- 5 Stocks Geared for Growth – The Motley Fool
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
- 5 Stocks Making Cash – The Motley Fool
- A Big Upgrade for Sanofi-Aventis – The Motley Fool
- The Worst Stocks to Buy Today – The Motley Fool
- The Hottest Sector for 2010 – The Motley Fool
- 5-Star Stocks Poised to Pop: American Oriental Bioengineering – The Motley Fool
- 5-Star Stocks Worth a Look – The Motley Fool
- A Big Upgrade for Gilead Sciences – The Motley Fool
- 5-Star Stocks Poised to Pop: Gilead Sciences – The Motley Fool
- Buy This Investment If You Want to Lose Money – The Motley Fool
- How Much Is Management Costing You? – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- Two Fools Featured in Barron's – The Motley Fool
- Saved by Emerging Markets. Sort Of. – The Motley Fool
- CNBC on Gilead Sciences, Inc. – Ockham-RazorWire
- The Next Home Run Stock – The Motley Fool
- Swine Flu Doesn't Need to Save Novartis – The Motley Fool
- CNBC on Gilead Sciences, Inc. – Ockham-RazorWire
- What Are You Waiting For? – The Motley Fool
RSS Headlines
Fool UK
